SEC Tracker
Get the app

Arcadia Biosciences RKDA

Arcadia Biosciences Q1 FY24: revenue $1.3M; diluted EPS −$1.78

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Arcadia Biosciences reported for Q1 FY24, the quarter ended Mar 31, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$1.3MNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income−$2.4MNo year-earlier figure tagged10-Q income statement, on EDGAR
  3. Diluted EPS−$1.78No year-earlier figure tagged10-Q income statement, on EDGAR
  4. Cash and cash equivalents$3.3MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations−$3.2MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Arcadia Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 1311 and related industry codes: the same peer list as the financial tables.

  1. New Concept Energy GBR public float $5M, Jun 30, 2025
  2. Barnwell Industries BRN public float $5M, Mar 31, 2025, over 18 months old
  3. Battalion Oil BATL public float $5M, Jun 30, 2025
  4. Viking Global Technologies CEIN public float $8M, Jun 30, 2025
  5. Trio Petroleum TPET public float $9M, Apr 30, 2025, over 18 months old